Cancer Stem Cell & Oncology Research

Navigate the ethical and societal considerations in cancer stem cell research and therapy, ensuring responsible conduct and equitable access to emerging treatments. This track addresses key ethical issues related to patient consent, privacy, data sharing, and the equitable distribution of resources in cancer stem cell research and clinical practice. Gain insights into the ethical challenges posed by novel technologies, such as genome editing and artificial intelligence, and explore strategies for promoting transparency, integrity, and patient welfare in cancer stem cell research. From regulatory frameworks to professional standards, this track provides a forum for discussing the ethical dimensions of cancer stem cell research and therapy, fostering responsible innovation and patient-centered care.

Investigate the impact of environmental factors, such as hypoxia, inflammation, and the microbiome, on cancer stem cell biology and tumor progression. This track explores how extrinsic cues from the tumor microenvironment and systemic factors influence cancer stem cell behavior and therapeutic responses. Discover how environmental stressors shape the adaptive capacity and therapeutic resistance of cancer stem cells, offering new insights into tumor heterogeneity and treatment failure. From the tumor immune microenvironment to the gut microbiome, this track highlights the complex interplay between environmental factors and cancer stem cell biology, informing novel therapeutic strategies and preventive interventions.

Harness CRISPR-based approaches for studying cancer stem cells, including gene editing, functional genomics, and therapeutic applications. This track explores the latest advancements in CRISPR technology for interrogating cancer stem cell biology and developing targeted therapies. Discover how CRISPR-mediated gene editing enables precise manipulation of cancer stem cell genomes, uncovering novel therapeutic targets and therapeutic vulnerabilities. From CRISPR screens to CRISPR-based therapeutics, this track offers insights into the transformative potential of genome editing in cancer stem cell research and precision oncology.

Explore the application of nanotechnology for targeted drug delivery, imaging, and theranostics in cancer stem cell research and therapy. This track highlights the latest advancements in nanomaterial design, synthesis, and characterization for cancer stem cell targeting and treatment. Discover how nanotechnology-based approaches are revolutionizing drug delivery, enhancing therapeutic efficacy, and reducing systemic toxicity in cancer patients. From nanoparticle-based drug carriers to nano-bio interfaces, this track offers insights into the exciting potential of nanotechnology in advancing cancer stem cell research and clinical translation.

Address the unique challenges and opportunities in targeting cancer stem cells in pediatric cancers. This track focuses on the molecular drivers, therapeutic vulnerabilities, and long-term survivorship outcomes in pediatric oncology. Gain insights into the distinct biology and treatment considerations of childhood cancers, including neuroblastoma, leukemia, and brain tumors, with a specific emphasis on personalized therapies and precision medicine approaches. Discover how advances in cancer stem cell research are transforming the landscape of pediatric oncology, offering hope for improved outcomes and quality of life for young cancer patients.

Explore the utility of patient-derived models, including organoids, patient-derived xenografts (PDX), and patient-derived tumor organoids (PDTO), for studying cancer stem cell biology and drug screening. This track highlights the advantages and limitations of different patient-derived model systems, offering insights into their relevance for understanding tumor heterogeneity, drug response, and therapeutic resistance. Discover how patient-derived models are shaping preclinical drug development and personalized medicine approaches in oncology, offering new opportunities for translational research and therapeutic innovation.

<span style="color: rgb(13, 13, 13); font-family: Söhne, ui-sans-serif, system-ui, -apple-system, " segoe="" ui",="" roboto,="" ubuntu,="" cantarell,="" "noto="" sans",="" sans-serif,="" "helvetica="" neue",="" arial,="" "apple="" color="" emoji",="" "segoe="" ui="" symbol",="" emoji";="" font-size:="" 16px;="" white-space-collapse:="" preserve;="" background-color:="" rgb(255,="" 255,="" 255);"="">Explore the application of artificial intelligence (AI) and machine learning in cancer stem cell research, including predictive modeling, drug discovery, and personalized medicine. This track highlights the latest advancements in AI-driven approaches for analyzing complex biological data, identifying novel therapeutic targets, and predicting treatment responses in cancer patients. Discover how AI algorithms and computational models are revolutionizing cancer stem cell research and clinical practice, offering new opportunities for precision oncology and personalized therapy.

Explore the role of exosomes in mediating intercellular communication between cancer stem cells and the tumor microenvironment, with implications for tumor progression and therapy resistance. This track delves into the biogenesis, cargo, and functions of cancer stem cell-derived exosomes, uncovering their role in tumor-stromal interactions, immune modulation, and therapy resistance. Discover how exosome-based biomarkers and therapeutic strategies hold promise for improving cancer diagnosis, prognosis, and treatment outcomes.

Understand the mechanisms of therapeutic resistance in cancer stem cells and explore strategies to overcome resistance and improve treatment outcomes. This track focuses on the molecular mechanisms underlying resistance to chemotherapy, targeted therapy, and immunotherapy in cancer stem cells. Discover how cancer stem cell plasticity, niche interactions, and microenvironmental factors contribute to therapy resistance, and explore innovative therapeutic approaches to overcome these challenges.

Delve into the intricate world of cancer stem cell biology, where the latest insights into molecular mechanisms governing self-renewal and differentiation await exploration. Uncover the dynamic interplay between genetic and epigenetic factors shaping the behavior of cancer stem cells, influencing tumor initiation, progression, and response to therapy. This track offers a platform to discuss groundbreaking research elucidating key pathways and regulatory networks driving cancer stem cell function. Attendees will gain invaluable insights into the fundamental processes underlying cancer stem cell biology, paving the way for innovative approaches to cancer treatment.

Investigate the significance of circulating tumor cells (CTCs) and disseminated cancer stem cells (CSCs) in metastasis, therapy resistance, and minimal residual disease detection. This track explores the latest advancements in CTC and CSC research, including their molecular characterization, functional significance, and clinical implications. Discover how CTC and CSC detection technologies are revolutionizing cancer diagnosis, prognosis, and treatment monitoring, offering new opportunities for personalized medicine and precision oncology.

Explore the role of stem cell niches in maintaining cancer stem cell populations and influencing tumor initiation, progression, and metastasis. Delve into the intricate signaling networks and cellular interactions within the stem cell niche, uncovering novel insights into how niche factors regulate cancer stem cell behavior and therapeutic responses. From niche-induced dormancy to niche-mediated metastasis, this track sheds light on the complex interplay between stem cell niches and the tumor microenvironment, offering new opportunities for therapeutic intervention.

Gain insights from ongoing clinical trials evaluating novel therapies targeting cancer stem cells. This track provides a comprehensive overview of the latest clinical trial data, including patient stratification strategies, biomarker development, and therapeutic outcomes. Learn about the challenges and opportunities in designing and conducting clinical trials focused on cancer stem cell-targeted therapies, and explore the potential implications for future treatment paradigms in oncology.

Discover emerging biomarkers and cutting-edge imaging techniques for the detection, characterization, and monitoring of cancer stem cells in vivo. Explore how advances in biomarker discovery and imaging technology are revolutionizing our ability to visualize and track cancer stem cells in real time, offering new insights into tumor biology and treatment response. From liquid biopsies to molecular imaging, this track highlights the latest innovations in biomarker development and imaging modalities for cancer stem cell research and clinical practice.

Unravel the epigenetic regulation of cancer stem cells and its profound impact on tumor heterogeneity, therapeutic resistance, and cellular plasticity. Dive into the intricate world of chromatin remodeling, DNA methylation, and histone modifications, exploring how epigenetic alterations shape cancer stem cell behavior and tumor progression. Gain insights into novel epigenetic targets and therapeutic approaches that hold promise for overcoming therapeutic resistance and improving patient outcomes in cancer.

Explore the metabolic plasticity of cancer stem cells and its implications for tumor growth, therapy response, and metabolic vulnerabilities. Delve into the intricate metabolic pathways and mechanisms that drive cancer stem cell behavior, offering new opportunities for therapeutic intervention. From targeting metabolic dependencies to exploiting metabolic vulnerabilities, this track sheds light on innovative strategies to disrupt cancer stem cell metabolism and improve treatment outcomes.

Unlock the potential of the immune system in targeting and eliminating cancer stem cells. This track focuses on the latest developments in immunotherapy, including immune checkpoint inhibitors, adoptive cell therapy, and cancer vaccines, with a specific emphasis on their application in targeting cancer stem cells. Discover how harnessing the power of the immune system holds promise for overcoming therapy resistance and achieving durable responses in cancer patients.

Embark on a journey through the latest advances in therapeutic targeting of cancer stem cells. Explore novel targets and innovative strategies designed to specifically eradicate these elusive cells, offering new hope for cancer treatment. From small molecule inhibitors to antibody-based therapies, delve into the cutting-edge approaches being developed to target and eliminate cancer stem cells, ultimately improving patient outcomes and survival rates.

Explore the multifaceted relationship between cancer stem cells and their surrounding microenvironment, a pivotal determinant of tumor progression and therapy resistance. Gain a comprehensive understanding of the intricate signaling networks and cellular interactions that shape the tumor microenvironment, influencing cancer stem cell behavior and therapeutic responses. From immune cell infiltration to extracellular matrix remodeling, this track delves into the dynamic interplay between cancer stem cells and their milieu, offering insights into novel therapeutic strategies to disrupt this critical axis of tumor biology. Join leading experts as they unravel the complexities of the tumor microenvironment and its implications for cancer stem cell biology and therapy.